Inventor
ALBRECHT BRIAN K
US52 patents
⚠️ This page may combine multiple inventors who share the name “ALBRECHT BRIAN K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CONSTELLATION PHARMACEUTICALS INC
17 patentsUS9469646B2Oct 18, 2016
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC21 citations92
US10016405B2Jul 10, 2018
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC3 citations84
US9745305B2Aug 29, 2017
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC11 citations84
US9624244B2Apr 18, 2017
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
CONSTELLATION PHARMACEUTICALS INC8 citations84
US9522920B2Dec 20, 2016
Bromodomain inhibitors and uses thereof
CONSTELLATION PHARMACEUTICALS INC10 citations84
US9409865B2Aug 9, 2016
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC14 citations83
US9371331B2Jun 21, 2016
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC8 citations83
US9206128B2Dec 8, 2015
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC10 citations83
US9051269B2Jun 9, 2015
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC9 citations83
US10526287B2Jan 7, 2020
LSD1 inhibitors and uses thereof
CONSTELLATION PHARMACEUTICALS INC2 citations73
US9980952B2May 29, 2018
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC3 citations73
US9969716B2May 15, 2018
Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC4 citations73
USRE47428EJun 11, 2019
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC0 citations52
US9925197B2Mar 27, 2018
Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereof
CONSTELLATION PHARMACEUTICALS INC1 citations52
US9493483B2Nov 15, 2016
Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereof
CONSTELLATION PHARMACEUTICALS INC1 citations52
US10035801B2Jul 31, 2018
Pyrazolo compounds and uses thereof
CONSTELLATION PHARMACEUTICALS INC1 citations49
US10577350B2Mar 3, 2020
Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
CONSTELLATION PHARMACEUTICALS INC0 citations45
GENENTECH INC
11 patentsUS9763922B2Sep 19, 2017
Therapeutic compounds and uses thereof
GENENTECH INC9 citations81
US10308614B2Jun 4, 2019
Therapeutic compounds and uses thereof
GENENTECH INC4 citations73
US10239861B2Mar 26, 2019
Therapeutic compounds and uses thereof
GENENTECH INC2 citations72
US10183009B2Jan 22, 2019
Therapeutic compounds and uses thereof
GENENTECH INC3 citations72
US9505767B2Nov 29, 2016
Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors
GENENTECH INC4 citations72
US10206931B2Feb 19, 2019
Therapeutic compounds and uses thereof
GENENTECH INC5 citations71
US10150767B2Dec 11, 2018
Therapeutic compounds and uses thereof
GENENTECH INC1 citations50
US10358437B2Jul 23, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10301253B2May 28, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10258603B2Apr 16, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations40
US10155764B2Dec 18, 2018
Therapeutic compounds and uses thereof
GENENTECH INC0 citations40
ALBRECHT BRIAN K
10 patentsUS9249161B2Feb 2, 2016
Bromodomain inhibitors and uses thereof
ALBRECHT BRIAN K50 citations93
US8796261B2Aug 5, 2014
Bromodomain inhibitors and uses thereof
ALBRECHT BRIAN K21 citations92
US8212041B2Jul 3, 2012
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K47 citations92
US8524900B2Sep 3, 2013
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K23 citations91
US8217177B2Jul 10, 2012
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K26 citations91
US8198448B2Jun 12, 2012
Fused heterocyclic derivatives and methods of use
ALBRECHT BRIAN K50 citations91
US9328117B2May 3, 2016
Bromodomain inhibitors and uses thereof
ALBRECHT BRIAN K8 citations84
US9422292B2Aug 23, 2016
Bromodomain inhibitors and uses thereof
ALBRECHT BRIAN K5 citations73
US8691838B2Apr 8, 2014
Heterocycles as protein kinase inhibitors
ALBRECHT BRIAN K3 citations62
US8314087B2Nov 20, 2012
Nitrogen-containing heterocyclyl ketones and methods of use
ALBRECHT BRIAN K0 citations41
AMGEN INC
7 patentsUS9066954B2Jun 30, 2015
Fused heterocyclic derivatives and methods of use
AMGEN INC22 citations91
US7880000B2Feb 1, 2011
Protein kinase modulators and method of use
AMGEN INC21 citations91
US7776869B2Aug 17, 2010
Heteroaryl-substituted alkyne compounds and method of use
AMGEN INC20 citations91
US7872009B2Jan 18, 2011
Beta-Secretase modulators and methods of use
AMGEN INC11 citations82
US7973047B2Jul 5, 2011
Beta-Secretase modulators and methods of use
AMGEN INC2 citations61
US7745484B2Jun 29, 2010
Beta-secretase modulators and methods of use
AMGEN INC2 citations60
US7838676B2Nov 23, 2010
Beta-secretase modulators and methods of use
AMGEN INC1 citations50
CONSTELLATION—PHARMACEUTICALS INC
1 patentCHAFFEE STUART C
1 patentGEUNS-MEYER STEPHANIE D
1 patentRELAY THERAPEUTICS INC
1 patentZHONG WENGE
1 patentShowing the top 50 of 52 patents by PatentIndex Score.